|
|
U.S. firm halts death penalty drug
|
|
The sole U.S. manufacturer of a key lethal injection drug said Jan. 21 it is ending production because of opposition overseas to capital punishment, a move that could delay executions across the United States. Over the past several months, a growing shortage of the drug, sodium thiopental, has forced some states to put executions on hold. Hospira Inc. said it decided in recent months to switch manufacturing from its North Carolina plant to a more modern factory in Liscate, Italy. But Italian authorities demanded a guarantee the drug would not be used to put inmates to death, an assurance the company said it wasn't willing to give. (AP)
死刑用の薬物メーカー、製造から撤退
米イリノイ州の製薬会社ホスピラは1月21日、国内のほとんどの死刑執行で使われている薬品「チオペンタールナトリウム」の製造から撤退すると発表した。
Shukan ST: February 4, 2011
(C) All rights reserved
|
|
|